Henry Schein reports record financial results for Q2 2013

Henry Schein has announced its financial results for the second quarter of 2013, during which it generated a record net sales total of $2.4 billion (1.54 billion pounds).

This represents a year-on-year increase of 8.6 percent, while earnings per share were up by 10.8 percent to $1.23, leading the company to raise the lower limit of its financial guidance for the full year.

Global dental sales increased by 6.2 percent to $1.3 billion, with dental market share rising through a combination of organic and acquisition growth, while its animal health and medical divisions also performed strongly.

The company also repurchased approximately 840,000 shares of its common stock during the second quarter at an average price of $92.99 per share.

Stanley Bergman, chairman of the board and chief executive officer of Henry Schein, said: "We continue to reap the benefits of our diversified business strategy as market share gains in each of our operating units resulted in record second-quarter global sales results."

Last month, Mr Bergman received an honorary fellowship from King's College London for exceptional distinction in his public and professional life.